Nuchal translucency measurement in first trimester Down syndrome screening

Area of Science:

• Prenatal Diagnosis
• Fetal Medicine
• Genetics

Background:

• Increased nuchal translucency (NT), a fluid buildup at the fetal neck, is observed in approximately 75% of fetuses with Down syndrome.
• Current screening methods combine NT ultrasound measurements with maternal age and serum biochemical markers.

Purpose of the Study:

• To evaluate the efficacy of nuchal translucency (NT) ultrasound in Down syndrome screening.
• To identify factors influencing the accuracy of NT measurements.
• To assess the need for standardization in NT screening protocols.

Main Methods:

• Ultrasound measurement of NT between 11 and 14 weeks' gestation.
• Integration of NT measurements with maternal age and placental biochemical markers.
• Analysis of factors affecting NT measurement accuracy, including fetal position, technique, software, and sonographer expertise.

Main Results:

• The combined screening approach (NT ultrasound, maternal age, biochemical markers) achieves an 84% detection rate for Down syndrome.
• Fetal position, measurement technique, risk-calculation software, and sonographer expertise significantly impact NT measurement accuracy.
• A need for a robust standardization and quality assurance system for NT measurement is highlighted.

Conclusions:

• Combined NT ultrasound screening offers a significant detection rate for Down syndrome.
• Standardization and quality assurance are crucial for the reliable and universal application of NT ultrasound screening.
• Further research or implementation planning is required to establish a universal NT screening program and assess associated costs.